Device is continuously infusing medication [device issue].Throat is sore [sore throat].Feels he received too much medication during his treatment [incorrect dose administered by device].Case description: this case is a spontaneous report from the united states received from a consumer via a specialty pharmacy on (b)(6) 2015.The pt was an adult male, exact age unk (born in 1974), of unk weight, hight and race, who first received tyvaso (treprostinil) via inhalation route on (b)(6) 2014 for pulmonary arterial hypertension.Inhaled (ih) treprostinil dosage was 42 micrograms (mcg) (seven breaths), four times daily, at the time of the events.Inhaled treprostinil was delivered via tyvaso inhalation system - nebulizer.Pt reports device (sn# (b)(4) ) continuously infusing medication (continuous nebulization).Further, the pt 'feels he received too much medication during his treatment and his throat is sore".The pt used 'back-up' device and replacements delivered overnight.(b)(4).Reporter's united states, name and address withheld.Device manufacture date: 11/2013.
|